The Potential Benefits and Adverse Effects of Phytic Acid Supplement in Streptozotocin-Induced Diabetic Rats

被引:23
|
作者
Omoruyi, F. O. [1 ]
Budiaman, A. [1 ]
Eng, Y. [1 ]
Olumese, F. E. [2 ]
Hoesel, J. L. [3 ]
Ejilemele, A. [3 ]
Okorodudu, A. O. [3 ]
机构
[1] Texas A&M Univ Corpus Christi, Ctr Sci, Dept Life Sci, 130B,6300 Ocean Dr,Unit 5802, Corpus Christi, TX 78412 USA
[2] Univ Benin, Dept Med Biochem, Benin, Nigeria
[3] Univ Texas Med Branch, Dept Pathol, Clin Chem Div, Galveston, TX 77555 USA
关键词
D O I
10.1155/2013/172494
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, the effect of phytic acid supplement on streptozotocin-induced diabetic rats was investigated. Diabetic rats were fed rodent chow with or without phytic acid supplementation for thirty days. Blood and organ samples were collected for assays. The average food intake was the highest and the body weight gain was the lowest in the group fed phytic acid supplement compared to the diabetic and normal control groups. There was a downward trend in intestinal amylase activity in the group fed phytic acid supplement compared to the other groups. The spike in random blood glucose was the lowest in the same group. We noted reduced serum triglycerides and increased total cholesterol and HDL cholesterol levels in the group fed phytic acid supplement. Serum alkaline phosphatase and alanine amino transferase activities were significantly (p < 0.05) increased by phytic acid supplementation. Systemic IL-1 beta level was significantly (p < 0.05) elevated in the diabetic control and supplement treated groups. The liver lipogenic enzyme activities were not significantly altered among the groups. These results suggest that phytic acid supplementation may be beneficial in the management of diabetes mellitus. The observed adverse effect on the liver may be due to the combined effect of streptozotocin-induced diabetes and phytic acid supplementation.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats
    Meral Koyuturk
    Sevim Tunali
    Sehnaz Bolkent
    Refiye Yanardag
    Biological Trace Element Research, 2005, 104 : 233 - 247
  • [32] Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats
    Yamano, M
    Kamato, T
    Nagakura, Y
    Miyata, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (01) : 145 - 150
  • [33] Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats
    Koyuturk, M
    Tunali, S
    Bolkent, S
    Yanardag, R
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2005, 104 (03) : 233 - 247
  • [34] Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats
    Kumar, Binit
    Gupta, Suresh Kumar
    Nag, Tapas Chandra
    Srivastava, Sushma
    Saxena, Rohit
    Jha, Kumar Abhiram
    Srinivasan, Bharthu Parthasarthy
    EXPERIMENTAL EYE RESEARCH, 2014, 125 : 193 - 202
  • [36] Effects of Nefopam on Streptozotocin-Induced Diabetic Neuropathic Pain in Rats
    Nam, Jae Sik
    Cheong, Yu Seon
    Karm, Myong Hwan
    Ahn, Ho Soo
    Sim, Ji Hoon
    Kim, Jin Sun
    Choi, Seong Soo
    Leem, Jeong Gil
    KOREAN JOURNAL OF PAIN, 2014, 27 (04): : 326 - 333
  • [37] Effects of melatonin on streptozotocin-induced diabetic liver injury in rats
    Guven, Aysel
    Yavuz, Ozlem
    Cam, Meryem
    Ercan, Feriha
    Bukan, Neslihan
    Comunoglu, Cem
    Gokce, Fatih
    ACTA HISTOCHEMICA, 2006, 108 (02) : 85 - 93
  • [38] Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats
    M. Yamano
    Takeshi Kamato
    Yukinori Nagakura
    Keiji Miyata
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 356 : 145 - 150
  • [39] Effects of Sleeve Gastrectomy in Neonatally Streptozotocin-Induced Diabetic Rats
    Wang, Yan
    Yan, Lingling
    Jin, Zhendong
    Xin, Xin
    PLOS ONE, 2011, 6 (01):
  • [40] EFFECTS OF CHRONIC NIFEDIPINE TREATMENT ON STREPTOZOTOCIN-INDUCED DIABETIC RATS
    SHAH, TS
    SATIA, MC
    GANDHI, TP
    BANGARU, RA
    GOYAL, RK
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (01) : 6 - 12